- Medical Device Testing Guide
- Preclinical Medical Device Test Request Forms
- Preclinical Safety Testing for Pharma and Biotech
- Business Development and Client Services
- White Papers
- Sponsor Package
- Ensuring Patient Safety of Medical Devices
Frequently Asked Questions (FAQs)
If you have questions about Toxikon's services and capabilities, send us an e-mail. We look forward to hearing from you! Below are some of frequently asked questions.
Q: How are issues of intellectual property handled?
A: Any and all intellectual property is owned by the client/sponsor, and Toxikon works exclusively for, and on behalf of, the client/study sponsor. The research services contract is specific in regards to client/sponsor ownership of results, intellectual property and publication rights.
Q: Can results be published without Toxikon’s authorship?
A: Yes. The results belong to the client/study sponsor and can therefore be published in any form and with any authorship the client/sponsor prefers. However, Toxikon takes pride in providing more than just results and we would like the opportunity to be involved in all aspects of data reporting and communication. Doing so reflects the strong relationships we build with our clients and sponsors, and that allows them to access to the wealth of thought leadership at Toxikon.
Q: Can you speak on the value of getting in-house generated results validated by an independent party?
A: Before advancing a compound or device to the clinical development stage, many investigators require the reproduction and validation of in-house data by another laboratory. A preclinical CRO, like Toxikon, is positioned to provide an unbiased study based on the original, which can validate existing efficacy data and allow the product to be developed with the confidence that the efficacy data is robust and reliable.
Q: Can models be customized?
A: Any study Toxikon undertakes can be customized.